Every year almost 500,000 new patients are diagnosed with hepatocellular carcinoma
(HCC), a primary malignancy of the liver that is associated with a poor prognosis. Numerous …

As discussed in detail in other chapters of this review, chronic hepatitis B (HBV) infection is a
major risk factor for hepatocellular carcinoma (HCC). Most HCCs complicate the evolution of …

Many factors are considered to contribute to hepatitis B virus (HBV) associated
hepatocellular carcinoma (HCC), including products of HBV, HBV integration and mutation …

AIM: To evaluate the anticancer property of the dried latex (DL) of Calotropis procera, a
tropical medicinal plant, in the X15-myc transgenic mouse model of hepatocellular …

Chronic infection with hepatitis viruses represents the major causative factor for end-stage
liver diseases, including liver cirrhosis and primary liver cancer (hepatocellular carcinoma …

Hepatocellular carcinoma and cholangiocarcinoma are primary liver cancers, both represent
a growing challenge for clinicians due to their increasing morbidity and mortality. In the last …

Hepatocellular carcinoma (HCC) ranks as the third most common cause of death from
cancer worldwide. Although major risk factors for the development of HCC have been …

Over 35 years ago, c-MYC, a highly pleiotropic transcription factor that regulates hepatic cell
function, was identified. In recent years, a considerable increment in the number of …

ETHNOPHARMACOLOGICAL RELEVANCE: Butea monosperma (Lam.)(Fabaceae)
popularly known as 'flame of the forest'has been widely used in the traditional Indian …

Chronic hepatitis B (HBV) infection is a major risk factor for hepatocellular carcinoma (HCC).
Most HCCs complicate the evolution of an active or inactive cirrhosis. However, some …